LAS VEGAS, NV--(Marketwired - Apr 3, 2014) - Earth Science Tech, Inc. (OTCQB: UNOV) ("EST" or "the Company"), a specialty biotechnology company focused on nutraceuticals and bioceuticals, is pleased to announce that it has changed its name from "Ultimate Novelty Sports, Inc." to "Earth Science Tech, Inc.". EST believes the name "Earth Science Tech" better reflects the nature of its business operations. Shareholder approval for the name change was obtained at the Company's Meeting held on February 21, 2014. There will be changes to the company's management to reflect the new direction and business plan of the company.
EST has informed FINRA of the name change and is waiting for a new trading symbol. As a public company, EST will have access to the capital markets essential to fund the company's growth strategies and feels the opportunities are substantial.
About: Earth Science Tech, Inc. (EST) is a unique biotechnology company focused on cutting edge nutraceuticals and bioceuticals. The company provides seamless science-based solutions designed to excel in industries such as health, wellness, nutrition, supplement, cosmetic and alternative medicine to improve the quality of life for consumers worldwide.
EST is focused on delivering nutritional and dietary supplements that help with treating symptoms such as: chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging and overall wellness. EST is dedicated in providing all natural alternatives to prescription medications that help improve common disorders and illnesses such as: diabetes, certain types of cancers, epilepsy, Alzheimer's disease, glaucoma, psychosis, Parkinson's disease, schizophrenia, rheumatoid arthritis, cerebral ischemia, social anxiety, autoimmune disorder, eczema, psoriasis, digestive diseases and more. This may include products such as vitamins, minerals, herbs, botanicals, personal care products, homeopathics, functional foods, and other products. These products will be in various formulations and delivery forms including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
Forward Looking Disclaimer: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.